Cholecystokinin and thermoregulation—a minireview

[1]  Q. Pittman,et al.  Vagal CCK and 5-HT3receptors are unlikely to mediate LPS or IL-1β-induced fever , 2000 .

[2]  V. Viau,et al.  A Cholecystokinin-Mediated Pathway to the Paraventricular Thalamus Is Recruited in Chronically Stressed Rats and Regulates Hypothalamic-Pituitary-Adrenal Function , 2000, The Journal of Neuroscience.

[3]  R. Dantzer,et al.  Cholecystokinin receptors do not mediate the suppression of food-motivated behavior by lipopolysaccharide and interleukin-1 beta in mice , 2000, Physiology & Behavior.

[4]  F. Hamel,et al.  Effects of paraventricular nucleus injection of CCK-8 on plasma CCK-8 levels in rats , 2000, Brain Research.

[5]  H. Sei,et al.  Spontaneous activity, sleep, and body temperature in rats lacking the CCK-A receptor , 1999, Physiology & Behavior.

[6]  A. A. Romanovsky,et al.  Vagotomy does not affect thermal responsiveness to intrabrain prostaglandin E2 and cholecystokinin octapeptide , 1999, Brain Research.

[7]  M. Kavaliers,et al.  Differential effects of lipopolysaccharide and cholecystokinin on sucrose intake and palatability. , 1999, American journal of physiology. Regulatory, integrative and comparative physiology.

[8]  R. Reidelberger,et al.  Relative Blood‐brain Barrier Permeabilities of the Cholecystokinin Receptor Antagonists Devazepide and A‐65186 in Rats , 1999, The Journal of pharmacy and pharmacology.

[9]  Akil,et al.  Evidence that Cholecystokinin Receptors are not Involved in the Hypothalamic‐Pituitary‐Adrenal Response to Intraperitoneal Administration of Interleukin‐1β , 1999, Journal of neuroendocrinology.

[10]  M. Zarrindast,et al.  Cholecystokinin and morphine-induced hypothermia , 1999, European Neuropsychopharmacology.

[11]  I. Kilpatrick,et al.  Preferential blockade of cholecystokinin-8S-induced increases in aspartate and glutamate levels by the CCK(B) receptor antagonist, L-365,260, in rat brain. , 1998, European journal of pharmacology.

[12]  M. Adler,et al.  Effect of a μ-Selective Opioid Antagonist on CCK-8–Induced Changes in Thermoregulation in the Rat , 1998, Pharmacology Biochemistry and Behavior.

[13]  H. Mönnikes,et al.  Peripheral administration of cholecystokinin activates c-fos expression in the locus coeruleus/subcoeruleus nucleus, dorsal vagal complex and paraventricular nucleus via capsaicin-sensitive vagal afferents and CCK-A receptors in the rat , 1997, Brain Research.

[14]  Y. Taché,et al.  Synergistic interaction between leptin and cholecystokinin to reduce short-term food intake in lean mice. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[15]  M. Székely,et al.  Role of Substance P (SP) in the Mediation of Endotoxin (LPS) Fever in Rats , 1997, Annals of the New York Academy of Sciences.

[16]  M. Adler,et al.  Interaction of cholecystokinin and somatostatin with a selective μ-opioid agonist and μ- and κ- antagonists in thermoregulation , 1997, Brain Research.

[17]  M. Székely,et al.  Autonomic cold- and heat-defence of rats during a febrile rise in core temperature induced by intracerebroventricular infusion of prostaglandin E1 , 1996 .

[18]  S. Curry,et al.  Whole body autoradiography of CCK-8 in rats , 1995, Regulatory Peptides.

[19]  G. Stalla,et al.  In man the mu-opiate agonist loperamide specifically inhibits ACTH secretion induced by the cholecystokinin-like peptide ceruletide. , 1994, Neuroendocrinology.

[20]  A. A. Romanovsky,et al.  Cholecystokinin octapeptide (CCK-8) injected into a cerebral ventricle induces a fever-like thermoregulatory response mediated by type B CCK-receptors in the rat , 1994, Brain Research.

[21]  Manuel F. Gonzalez,et al.  The induction and suppression of c-fos expression in the rat brain by cholecystokinin and its antagonist L364,718 , 1993, Neuroscience Letters.

[22]  E. South.  Cholecystokinin reduces body temperature in vehicle- but not capsaicin-pretreated rats. , 1992, The American journal of physiology.

[23]  S. Matsukura,et al.  Stimulation of cholecystokinin (CCK) release from superfused rat hypothalamo-neurohypophyseal complexes by interleukin-1 (IL-1) , 1992, Brain Research.

[24]  M. Kluger.  Fever: Role of Pyrogens and Cryogens , 1991, Physiological reviews.

[25]  B. Penke,et al.  Cholecystokinin interferes with the thermoregulatory effect of exogenous and endogenous opioids , 1989, Neuropeptides.

[26]  L. Barthó,et al.  Can the hypothermia elicited by peripheral injection of CCK-8 in the rat be regarded as a centrally mediated thermoregulatory response? , 1989 .

[27]  T. Nagasaka,et al.  Changes in brown adipose tissue metabolism following intraventricular vasoactive intestinal peptide and other gastrointestinal peptides in rats. , 1989, The Japanese Journal of Physiology.

[28]  B. Penke,et al.  Effects of nocturnal intraperitoneal administration of cholecystokinin in rats: simultaneous increase in sleep, increase in EEG slow-wave activity, reduction of motor activity, suppression of eating, and decrease in brain temperature , 1988, Brain Research.

[29]  C. Savory.  An alternative explanation for apparent satiating properties of peripherally administered bombesin and cholecystokinin in domestic fowls , 1987, Physiology & Behavior.

[30]  R. Pullen,et al.  Penetration of diazepam and the non‐peptide CCK antagonist, L‐364, 718, into rat brain , 1987, The Journal of pharmacy and pharmacology.

[31]  A. Inui,et al.  The role of cholecystokinin octapeptide in the central control of food intake in the dog , 1987, Peptides.

[32]  W. Wuttke,et al.  Stress-induced changes in cholecystokinin and substance P concentrations in discrete regions of the rat hypothalamus. , 1987, Neuroendocrinology.

[33]  S. Demesquita,et al.  Effect of chronic intracerebroventricular infusion of cholecystokinin on respiration and sleep , 1986, Brain Research.

[34]  J. Hughes,et al.  High concentrations of cholecystokinin receptor binding sites in the ventromedial hypothalamic nucleus , 1986, Neuropeptides.

[35]  W. Banks,et al.  Central nervous system effects of peptides, 1980–1985: A cross-listing of peptides and their central actions from the first six years of the journal Peptides , 1986, Peptides.

[36]  G. Greeley,et al.  Blood‐CSF barrier to CCK and effect of centrally administered bombesin on release of brain CCK , 1986, Journal of neuroscience research.

[37]  M. Lin,et al.  Cholecystokinin-induced hypothermia: possible involvement of serotoninergic mechanisms in the rat hypothalamus. , 1985, Pharmacology.

[38]  M. Palkovits,et al.  Cholecystokinin in the nucleus of the solitary tract of the rat: evidence for its vagal origin , 1982, Brain Research.

[39]  R. D. Myers,et al.  Eating, drinking and temperature responses to intracerebroventricular cholecystokinin in the chick , 1982, Peptides.

[40]  G. Zetler.  Cholecystokinin octapeptide, caerulein and caerulein analogues: Effects on thermoregulation in the mouse , 1982, Neuropharmacology.

[41]  W. Oldendorf,et al.  Rapid appearance of intraventricularly administered neuropeptides in the peripheral circulation , 1982, Brain Research.

[42]  M. Palkovits,et al.  Distribution of cholecystokinin (CCK) in the hypothalamus and limbic system of the rat , 1981, Neuropeptides.

[43]  J. Morley,et al.  Intraventricular cholecystokinin-octapeptide produces hypothermia in rats. , 1981, European journal of pharmacology.

[44]  S. Itoh,et al.  Effect of cholecystokinin octapeptide on body temperature in the rat. , 1981, The Japanese journal of physiology.

[45]  W. G. Clark.  Changes in body temperature after administration of amino acids, peptides, dopamine, neuroleptics and related agents , 1979, Neuroscience & Biobehavioral Reviews.

[46]  G. P. Smith,et al.  Cholecystokinin decreases food intake in rats. , 1973, Journal of comparative and physiological psychology.